We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Medical Properties (MPW) Stock Moves -1.15%: What You Should Know
Read MoreHide Full Article
In the latest trading session, Medical Properties (MPW - Free Report) closed at $5.14, marking a -1.15% move from the previous day. The stock outperformed the S&P 500, which registered a daily loss of 2.06%. At the same time, the Dow lost 1.76%, and the tech-heavy Nasdaq lost 2.39%.
Shares of the health care real estate investment trust witnessed a gain of 2.56% over the previous month, beating the performance of the Finance sector with its gain of 1.72%, and the S&P 500's gain of 1.63%.
Analysts and investors alike will be keeping a close eye on the performance of Medical Properties in its upcoming earnings disclosure. In that report, analysts expect Medical Properties to post earnings of $0.15 per share. This would mark a year-over-year decline of 16.67%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $245.22 million, up 5.77% from the year-ago period.
For the full year, the Zacks Consensus Estimates are projecting earnings of $0.55 per share and revenue of $946.9 million, which would represent changes of -31.25% and 0%, respectively, from the prior year.
Investors might also notice recent changes to analyst estimates for Medical Properties. Recent revisions tend to reflect the latest near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 2.81% increase. Right now, Medical Properties possesses a Zacks Rank of #2 (Buy).
Looking at its valuation, Medical Properties is holding a Forward P/E ratio of 7.7. This expresses a discount compared to the average Forward P/E of 11.41 of its industry.
The REIT and Equity Trust - Other industry is part of the Finance sector. This group has a Zacks Industry Rank of 170, putting it in the bottom 31% of all 250+ industries.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Medical Properties (MPW) Stock Moves -1.15%: What You Should Know
In the latest trading session, Medical Properties (MPW - Free Report) closed at $5.14, marking a -1.15% move from the previous day. The stock outperformed the S&P 500, which registered a daily loss of 2.06%. At the same time, the Dow lost 1.76%, and the tech-heavy Nasdaq lost 2.39%.
Shares of the health care real estate investment trust witnessed a gain of 2.56% over the previous month, beating the performance of the Finance sector with its gain of 1.72%, and the S&P 500's gain of 1.63%.
Analysts and investors alike will be keeping a close eye on the performance of Medical Properties in its upcoming earnings disclosure. In that report, analysts expect Medical Properties to post earnings of $0.15 per share. This would mark a year-over-year decline of 16.67%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $245.22 million, up 5.77% from the year-ago period.
For the full year, the Zacks Consensus Estimates are projecting earnings of $0.55 per share and revenue of $946.9 million, which would represent changes of -31.25% and 0%, respectively, from the prior year.
Investors might also notice recent changes to analyst estimates for Medical Properties. Recent revisions tend to reflect the latest near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 2.81% increase. Right now, Medical Properties possesses a Zacks Rank of #2 (Buy).
Looking at its valuation, Medical Properties is holding a Forward P/E ratio of 7.7. This expresses a discount compared to the average Forward P/E of 11.41 of its industry.
The REIT and Equity Trust - Other industry is part of the Finance sector. This group has a Zacks Industry Rank of 170, putting it in the bottom 31% of all 250+ industries.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.